Ras in cancer and developmental diseases.

By A. Fernández-Medarde, E. Santos. Genes & cancer, 2011

849 citations recorded by the source corpus.

Subfields: Molecular Biology

View Paper: https://www.semanticscholar.org/paper/d07c928e55ede2e82810f61228016aabcb20777d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Ping Wee
2. Zhixiang Wang

Citations in the corpus

• A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer (2019, background): “These mutations are indicators of cancer aggressiveness and are commonly correlated with unfavorable prognosis in patients [32].”
• Risk Factors and Preventions of Breast Cancer (2017, background): “H-ras overexpression is detected in both primary and advanced breast cancer patients, indicating a poor prognosis [49, 50].”
• Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways (2017, background): “It is estimated that up to 30% of all human tumours carry some mutation in the RAS genes [167].”
• Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. (2013, neutral): “Mutated 24/320 (8) 29/321 (9) 53/641 (8)”